1
Alogliptin, a potent and selective dipeptidyl peptidase-IV inhibitor for the treatment of type 2 diabetes
CF Deacon
Current Opinion in Investigational Drugs 4 April 2008,402-413
Код: Выделить всё
http://www.biomedcentral.com/render/render.asp?arx_id=cd-893178&type=pdf&access=denied